JAN SUNDE to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications JAN SUNDE has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.037
-
A phase I trial of oxaliplatin and topotecan in recurrent ovarian carcinoma. Gynecol Oncol. 2007 Feb; 104(2):422-7.
Score: 0.037
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.